Sopharma AD (the “Company”) announces that on 16 July 2015 the Company bought 240 000 shares from the capital of Medika AD. After this transaction, the share of Sopharma AD in the capital of Medika AD increased to 36.10%.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 25 October 2012 up to and including 31 October 2012 the Company bought 162303 own shares representing 0.123% of the share capital of the Company, to the total value of BGN 382683.79 on the Bulgarian Stock Exchange. The average price per share was BGN 2.36.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

Sopharma AD (the “Company”) hereby notifies that on 3 August 2015 Sopharma AD received a notification of disclosure of shareholdings from Telekomplekt invest AD regarding the purchasing of 108 700 shares. After this transaction the share of Telekomplekt invest AD in the capital of Sopharma AD reached 20.07%.
The date of registration of the transaction with the Central Depository AD is 31 July 2015.

Sopharma AD (the “Company”) hereby notifies that on 4 August 2015 Sopharma AD received a notification of disclosure of shareholdings from Telso AD regarding the selling of 397 057 shares. After this transaction the share of Telso AD in the capital of Sopharma AD decreased below 5%.The date of registration of the transaction with the Central Depository AD is 31 July 2015.

Sopharma AD notifies that for July 2015 the Company recorded a decrease of sales revenues of 27% compared to the same month of 2014, including same level of domestic sales and 56% decrease of export sales.
For the first seven months of this year, revenues from sales decreased by 18% compared to the same period of 2014, including 9% increase of domestic sales and a 30% decrease of export sales.

SOPHARMA AD hereby informs that from 29 July 2015 up to and including 05 August 2015 the Company bought 350 own shares representing 0.00026% of the share capital of the Company, at a total value of 975.90 BGN on the Bulgarian Stock Exchange, the average price per share was 2.703 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 175 182, representing 3.84% of the share capital of the Company.

SOPHARMA AD hereby informs that from 20 August 2015 up to and including 26 August 2015 the Company bought 500 own shares representing 0.0004% of the share capital of the Company, at a total value of 1320.00 BGN on the Bulgarian Stock Exchange, the average price per share was 2.64 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 175 682, representing 3.84% of the share capital of the Company.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 11 October 2012 up to and including 17 October 2012 the Company bought 1100 own shares representing 0.00083% of the share capital of the Company, to the total value of BGN 2640.00 on the Bulgarian Stock Exchange. The average price per share was BGN 2.40.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

Sopharma AD notifies that for August 2015 the Company recorded an increase of sales revenues of 1% compared to the same month of 2014, including 5% decrease of domestic sales and 4% increase of export sales.

For the first eight months of this year, revenues from sales decreased by 15% compared to the same period of 2014, including 9% increase of domestic sales and a 26% decrease of export sales.

SOPHARMA AD hereby informs that from 3 September 2015 up to and including 9 September 2015 the Company bought 43 614 own shares representing 0.032% of the share capital of the Company.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 219 296, representing 3.87% of the share capital of the Company.